SCHEMBL30150622

SCHEMBL30150622

Cc1ccc(C(=O)NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 7/20 0.64
▸ HDAC1 Q13547 4/20 0.64
▸ KCNQ3 O43525 2/20 0.47
▸ KCNQ2 O43526 2/20 0.47
▸ KCNE1 P15382 2/20 0.47
▸ KCNQ1 P51787 2/20 0.47
▸ KCNQ5 Q9NR82 1/20 0.47
▸ MTOR P42345 1/20 0.46
▸ LMNA P02545 2/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ MMP1 P03956 1/20 0.42
▸ MMP2 P08253 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ MMP8 P22894 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HDAC11 Q96DB2 2/20 0.40
▸ HDAC8 Q9BY41 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23388546 1.00 HDAC6 (0.64) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL30147494 0.75 HDAC6 (0.73) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL1441177 0.75 HDAC6 (0.73) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL18423953 0.74 HDAC1 (0.71) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL10703579 0.73 HDAC1 (0.63) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL23447717 0.72 KMT2A (0.63) LMNATP53MEN1ALDH1A1KMT2A
SCHEMBL3755988 0.71 HDAC1 (0.67) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL5707117 0.71 HDAC1 (0.67) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL13527485 0.71 HDAC1 (0.67) HDAC6HDAC1KCNQ3KCNQ2KCNE1
SCHEMBL14461364 0.71 HDAC1 (0.67) HDAC6HDAC1KCNQ3KCNQ2KCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF DUNAD THERAPEUTICS LTD. (GB) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF FURIN, PFAS, CFTR HDAC6 222/4885HDAC1 2414/4885KCNQ3 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback